Abstract
Neurodegenerative diseases are thought to be multifactorial, while metals (aluminum and manganese) can be involved as cofactors in abnormalities or suspected of being risk factors for this disorder. The aim of our study was to assess the aluminum (Al) and manganese (Mn) concentrations in scalp hair samples of 397 patients having different types of neurological disorder diseases. For comparative purpose, scalp hair samples of 201 control subjects does not have any neuro-disorders of same age group (30–60 years) and were selected as referents. The Al and Mn in scalp hair samples were assessed by the electrothermal atomic absorption spectrophotometry after microwave-assisted acid digestion. The validity of methodology was checked by the certified human hair reference material (NCS ZC81002). The results of this study showed that the mean values of Al and Mn were significantly higher in scalp hair samples of all types of neurological disorder patients as compared to controls (p = 0.01–0.001). The high levels of Al and Mn may play a role in the development of neurological disorders. However, further work is suggested to examine the precise correlation between trace elemental level and the degree of disorders in neurological patients.
Similar content being viewed by others
References
Afridi, H. I., Kazi, T. G., & Kazi, G. H. (2006). Analysis of heavy metals in scalp hair samples of hypertensive patients by conventional and microwave digestion methods. Spectroscopy letter, 39, 203–214.
Afridi, H. I., Kazi, T. G., Kazi, N., Jamali, M. K., Arain, M. B., Jalbani, N., & Shah, A. Q. (2008). Evaluation of status of toxic metals in biological samples of diabetes mellitus patients. Diabetes Research & Clinical Practice, 80, 280–288.
Afridi, H. I., Kazi, T. G., Kazi, N., Naeem, U., Arain, S. S., Brahman, K. D., & Wadhwa, S. K. (2013). Evaluation of chromium, cobalt and manganese in biological samples (scalp hair, blood, and urine) of Pakistani viral hepatitis (A-E) patients and controls. Clinical Laboratory, 59, 247–256.
Banks, W. A., Banks, A. J., & Zatta, P. (1995). The blood-brain barrier in aluminum toxicity and Alzheimer’s disease. In P. Zatta & M. Nicolini (Eds.), Non-neuronal cells in Alzheimer’s disease (pp. 1–12). Singapore: World Scientific.
Barnham, K. J., & Bush, A. I. (2008). Metals in Alzheimer’s and Parkinson’s diseases. Current Opinion Chemical Biology, 12, 222–228.
Bush, A. I. (2000). Metals and neuroscience. Current Opinion Chemical Biology, 4, 184–191.
Calne, D. B., Chu, N. S., Huang, C. C., Lu, C. S., & Olanow, W. (1994). Manganism and idiopathic Parkinsonism: similarities and differences. Neurology, 44, 1583–1586.
Citak, D., Tuzen, M., & Soylak, M. (2010). Speciation of Mn(II), Mn(VII) and total manganese in water and food samples by coprecipitation-atomic absorption spectrometry combination. Journal of Hazardous Materials, 173, 773–777.
Erasmus, R. T., Savory, J., Wills, M. R., et al. (1993). Aluminum neurotoxicity in experimental animals. Ther Drug Monitoring, 15, 588–592.
Exley, C. (2013). Human exposure to aluminium. Environental Science Processes & Impacts, 15, 1807–1816.
Favarato, M., Zatta, P., Perazzolo, M., Fontana, L., & Nicolini, M. (1992). Aluminum(III) influences the permeability of the blood-brain barrier to [14C]sucrose in rats. Brain Research, 569, 330–335.
Flaten, P. (2001). Aluminium as a risk factor in Alzheimer’s disease, with emphasis on drinking water. Brain Research Bulletin, 55, 187–196.
Gaytan-Garcia, S., Kim, H., & Strong, M. J. (1996). Spinal motor neuron neuroaxonal spheroids in chronic aluminum neurotoxicity contain phosphatase-resistant high molecular weight neurofilament. Toxicology, 108, 17–24.
IPCS. (1997). Environmental Health Criteria 194. WHO, Geneva: Aluminium.
Khan, S., Kazi, T. G., Baig, J. A., Afridi, H. I., & Kolach, N. F. (2011). Separation/preconcentration methods for the determination of aluminum in dialysate solution and scalp hair samples of kidney failure patients. Biological Trace Element Research, 144, 205–216.
Klein, G. L. (2005). Aluminium: new recognition of an old problem. Current Opinion Pharmacology, 5, 637–640.
Landeghem, G. F. V., Sikström, C., Beckman, L. E., Adolfsson, R., & Beckman, L. (1998). Transferrin C2, metal binding in Alzheimer’s disease. Neuroreport, 9, 177–179.
Levy, B. S., & Nassetta, W. J. (2003). Neurologic effects of manganese in humans. International Journal of Occupational and Environmental Health, 9, 153–163.
Lyden, A., Larsson, B. S., & Lindquist, N. G. (1984). Melanin affinity of manganese. Acta Pharmacological Toxicology (Copenhagen), 55, 133–138.
Meco, G., Bonifati, V., Vanacore, N., & Fabrizio, E. (1994). Parkinsonism after chronic exposure to the fungicide maneb (manganese ethylenebisdithiocarbamate). Scand Journal Work Environment Health, 20, 301–305.
Moore, P. B., Day, J. P., Taylor, G. A., Ferrier, I. N., Fifield, L. K., & Edwardson, J. A. (2000). Absorption of 26aluminium in Alzheimer’s disease, measured using accelerator mass spectrometry. Dementia and Geriatric Cognitive Disorders, 11, 66–69.
Namekata, K., Imagawa, M., Terashi, A., Ohta, S., Oyama, F., & Ihara, Y. (1997). Association of transferrin C2 allele with lateonset Alzheimer’s disease. Human Genetic, 101, 126–129.
Olanow, C. N. (2004). Manganese-induced Parkinsonism and Parkinson’s disease. Annals of the New York Academy of Sciences, 1012, 209–223.
Otezia, P. I., Keen, C. L., Han, B., et al. (1993). Aluminum accumulation and neurotoxicity in Swiss-Webster mice after long-term dietary exposure to aluminum and citrate. Metabolism, 42, 1296–1300.
Ozcan, S. G., Satiroglu, N., & Soylak, M. (2010). Column solid phase extraction of iron(III), copper(II), manganese(II) and lead(II) ions food and water samples on multi-walled carbon nanotubes. Food and Chemical Toxicology, 48, 2401–2406.
Pal, P. K., Samii, A., & Calne, D. B. (1999). Manganese neurotoxicity: a review of clinical features, imaging and pathology. Neurotoxicology, 20, 227–38.
Rensburg, S. J. V., Carstens, M. E., Potocnik, F. C. V., Aucamp, A. K., & Taljaard, J. J. F. (1993). Increased frequency of the transferrin C2 subtype in Alzheimer’s disease. Neuroreport, 4, 1269–1271.
Roberts, N. B., Clough, A., Bellia, J. P., & Kim, J. Y. (1998). Increased absorption of aluminium from a normal dietary intake in dementia. Journal of Inorganic Biochemistry, 69, 171–6.
Rondeau, V., Commenges, D., Gadda, H. J., & Dartigues, J. F. (2000). Relation between aluminum concentrations in drinking water andAlzheimer’s disease: an 8-year follow-up study. American Journal of Epidemiology, 152, 59–66.
Sjogren, B., Gustavsson, P., & Hogstedt, C. (1990). Neuropsychiatric symptoms among welders exposed to neurotoxic metals. British Journal of Industrial Medicine, 47, 704–707.
Sjogren, B., Iregren, A., Frech, W., Hagman, M., Johansson, L., Tesarz, M., & Wennberg, A. (1996). Effects on the nervous system among welders exposed to aluminium and manganese. Journal of Occupational and Environmental Medicine, 53, 32–40.
Sparks, D. L. (1997). Dietary cholesterol induces Alzheimer’s-like ß-amyloid immunoreactivity in rabbit brain. Nutritional Metabolism and Cardiovascular Diseases, 7, 255–266.
Tuzen, M., & Soylak, M. (2008). Biosorption of aluminum on pseudomonas aeruginosa loaded on chromosorb 106 prior to its graphite furnace atomic absorption spectrometric determination. Journal of Hazardous Materials, 154, 519–525.
Whitehead, M. W., Farrar, G., Christie, G. L., Blair, J. A., Thompson, R. P., & Powell, J. J. (1997). Mechanisms of aluminum absorption in rats. American Journal of Clinical Nutrition, 65, 1446–1452.
Yokel, R. A. (2006). Blood-brain barrier flux of aluminum, manganese, iron and other metals suspected to contribute to metal-induced neurodegeneration. Journal of Alzheimers Disease, 10, 223–253.
Yokel, R. A., Crossgrove, J. S., & Bukaveckas, B. L. (2003). Manganese distribution across the blood-brain barrier. II. Manganese efflux from the brain does not appear to be carrier mediated. Neurotoxicology, 24, 15–22.
Zatta, P., Zambenedetti, P., Stella, M. P., & Licastro, F. (2002). Astrocytosis, microgliosis, metallothionein-I-II and amyloid expression in high cholesterol-fed rabbits. Journal of Alzheimers Disease, 4, 1–9.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Arain, M.S., Afridi, H.I., Kazi, T.G. et al. Correlation of aluminum and manganese concentration in scalp hair samples of patients having neurological disorders. Environ Monit Assess 187, 10 (2015). https://doi.org/10.1007/s10661-014-4172-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10661-014-4172-0